MedTrace Logo

Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study

NCT00706784 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2014-06-26

Study results available
· View outcomes & findings →

Summary

This research study is looking at how well a new drug delivery system, called the vaginal ring, works to get hormones into your body as a form of birth control.

Conditions

  • Healthy

Interventions

DRUG

Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System

Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System

Sponsors & Collaborators

  • Combinent

    collaborator UNKNOWN

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Alexandra B. Kimball, MD, MPH · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2012-12-31
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00706784 on ClinicalTrials.gov